CVR: 39696614
Secondary names: Valeos A/S
Previous names: Valeos IVS, Valeos ApS, Valeos A/S
DKK 975,949
Gross profit
Net result: DKK -13,487,363
A. Rosen Holding ApS, MSG Capital APS
1 more
CVR · view ownership and management
Director role ended: Morten Larsen Snede
CVR · 26/05/2025
View the full event history
Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.
Virksomhedens formål er at dyrke medicinsk cannabis og hermed beslægtede produkter og hermed beslægtet virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 976 t. | -13.5 mio. | 52.8 mio. | -6.7 mio. | 19 | |
| 202401/01/2024 – 31/12/2024 | -3.8 mio. | -16.9 mio. | 58.1 mio. | 6.8 mio. | 19 | |
| 202301/01/2023 – 31/12/2023 | -5.8 mio. | -16.5 mio. | 61.1 mio. | -8.4 mio. | 18 | |
| 202201/01/2022 – 31/12/2022 | -6.5 mio. | -11.4 mio. | 57.3 mio. | 5.1 mio. | 10 | |
| 202101/01/2021 – 31/12/2021 | -3.4 mio. | -6.4 mio. | 49.9 mio. | 16.5 mio. | 7 | |
| 202001/01/2020 – 31/12/2020 | -1.3 mio. | -1.7 mio. | 22.2 mio. | -1.4 mio. | 2 |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningValeos Pharma A/S was founded on 3 July 2018.
Valeos Pharma A/S is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Valeos Pharma A/S is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS.
In 2025, Valeos Pharma A/S reported a gross profit of DKK 975,949.
The management of Valeos Pharma A/S consists of Peter Frederik Andreasen.
Valeos Pharma A/S is located at Østervej 2, 4960 Holeby.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 20651018 (July 29, 2026).
Valeos Pharma A/S has published its annual report for 2025. Gross profit came to DKK 975,949, and the net result was DKK -13,487,363.
As of September 4, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Valeos Pharma A/S.
As of September 4, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Valeos Pharma A/S.
Valeos Pharma A/S has published its annual report for 2024. Gross profit came to DKK -3,846,790, and the net result was DKK -16,944,710.
As of June 17, 2025, Glenn Steven Nielsen has joined the board of directors of Valeos Pharma A/S.
As of June 17, 2025, Henrik Kristian Moltke has left the board of directors of Valeos Pharma A/S.
As of May 26, 2025, Peter Frederik Andreasen is registered as adm. dir. of Valeos Pharma A/S.
As of May 26, 2025, Morten Larsen Snede has stepped down as adm. dir. of Valeos Pharma A/S.
As of November 7, 2024, A. Rosen Holding ApS is registered as an owner of Valeos Pharma A/S with an ownership share of 15%.
As of November 7, 2024, MSG Capital APS is registered as an owner of Valeos Pharma A/S with an ownership share of 50%.
As of November 7, 2024, Kleingut ApS is registered as an owner of Valeos Pharma A/S with an ownership share of 10%.
Valeos Pharma A/S has published its annual report for 2023. Gross profit came to DKK -5,838,506, and the net result was DKK -16,533,984.
As of February 12, 2024, Morten Larsen Snede is registered as adm. dir. of Valeos Pharma A/S.
As of February 12, 2024, Peter Frederik Andreasen has stepped down as adm. dir. of Valeos Pharma A/S.
Valeos Pharma A/S has published its annual report for 2022. Gross profit came to DKK -6,489,428, and the net result was DKK -11,425,601.
Valeos Pharma A/S has published its annual report for 2021. Gross profit came to DKK -3,379,088, and the net result was DKK -6,408,155.
As of July 4, 2022, Kristian Schrøder Hart-Hansen has joined the board of directors of Valeos Pharma A/S.
As of July 4, 2022, Henrik Kristian Moltke has joined the board of directors of Valeos Pharma A/S.
As of July 4, 2022, Glenn Steven Nielsen has left the board of directors of Valeos Pharma A/S.
On July 4, 2022, the company changed its name from Valeos A/S to Valeos Pharma A/S.
As of July 3, 2022, Kristian Schrøder Hart-Hansen has left the board of directors of Valeos Pharma A/S.
As of March 7, 2022, Farzad Jahanshahi is registered as adm. dir. of Valeos Pharma A/S.
As of March 7, 2022, Peter Frederik Andreasen is registered as adm. dir. of Valeos Pharma A/S.
As of March 7, 2022, Farzad Jahanshahi has stepped down as adm. dir. of Valeos Pharma A/S.
As of March 7, 2022, Birgitte Steen Frydland has stepped down as adm. dir. of Valeos Pharma A/S.
As of November 22, 2021, Peter Frederik Andreasen has stepped down as director of Valeos Pharma A/S.
As of October 11, 2021, Peter Frederik Andreasen has joined the board of directors of Valeos Pharma A/S.
As of October 11, 2021, Michael Andreasen has left the board of directors of Valeos Pharma A/S.
As of October 6, 2021, Peter Frederik Andreasen is registered as director of Valeos Pharma A/S.
As of October 6, 2021, Birgitte Steen Frydland is registered as adm. dir. of Valeos Pharma A/S.
As of October 5, 2021, Peter Frederik Andreasen has stepped down as adm. dir. of Valeos Pharma A/S.
Valeos Pharma A/S has published its annual report for 2020. Gross profit came to DKK -1,276,838, and the net result was DKK -1,704,956.
As of April 15, 2021, Kristian Schrøder Hart-Hansen has joined the board of directors of Valeos Pharma A/S.
As of April 15, 2021, Glenn Steven Nielsen has joined the board of directors of Valeos Pharma A/S.
As of April 14, 2021, Kristian Schrøder Hart-Hansen has left the board of directors of Valeos Pharma A/S.
As of April 14, 2021, Glenn Steven Nielsen has left the board of directors of Valeos Pharma A/S.
As of April 5, 2021, Kristian Schrøder Hart-Hansen has joined the board of directors of Valeos Pharma A/S.
As of April 5, 2021, Michael Andreasen has joined the board of directors of Valeos Pharma A/S.
As of April 5, 2021, Totti Hannu Miikael Vuosio has left the board of directors of Valeos Pharma A/S.
Valeos Pharma A/S has published its interim report for the period July 3, 2018 – December 31, 2019.
On March 10, 2020, the company changed its name from Valeos ApS to Valeos A/S.
As of November 18, 2019, A/S PSE 17 NR. 1056 has been appointed auditor of Valeos Pharma A/S.
As of November 18, 2019, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Valeos Pharma A/S.
As of November 18, 2019, Michael Halborg-Bendtsen has joined the board of directors of Valeos Pharma A/S.
As of November 18, 2019, Glenn Steven Nielsen has joined the board of directors of Valeos Pharma A/S.
As of November 18, 2019, Totti Hannu Miikael Vuosio has joined the board of directors of Valeos Pharma A/S.
On November 18, 2019, the company changed its name from Valeos IVS to Valeos ApS.
As of July 3, 2018, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of Valeos Pharma A/S.
As of July 3, 2018, Peter Frederik Andreasen is registered as adm. dir. of Valeos Pharma A/S.
Valeos Pharma A/S was founded on July 3, 2018.
1 news item or press release
Sources: Via Ritzau and Danish news media. Links open at the source.
Companies in the same industry and area
